Examining the evolving landscape of liver cancer burden in the United States from 1990 to 2019

被引:5
作者
Al Ta'ani, Omar [1 ]
Al-Ajlouni, Yazan [2 ]
Jagdish, Balaji [1 ]
Khataniar, Himsikhar [1 ]
Aleyadeh, Wesam [3 ,4 ]
Al-Bitar, Farah [5 ]
Singh, Tavankit [1 ]
机构
[1] Allegheny Hlth Network, 320 E North Ave, Pittsburgh, PA 15212 USA
[2] New York Med Coll, Sch Med, NYC, New York, NY USA
[3] Cleveland Clin Akron Gen, Akron, OH USA
[4] Toronto Ctr Liver Dis, Toronto, ON, Canada
[5] Western Mchigan Univ, Homer Stryker M D Sch Med, Kalamazoo, MI USA
关键词
Burden of disease; Hepatocellular carcinoma; United States; DALYs; Risk factors; Hepatitis B; Hepatitis C; Alcohol use; HEPATITIS-C VIRUS; HEPATOCELLULAR-CARCINOMA; BARIATRIC SURGERY; INJECT DRUGS; MORTALITY; DISEASE; EPIDEMIOLOGY; MANAGEMENT; DISPARITIES; INFECTION;
D O I
10.1186/s12885-024-12869-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Liver cancer (LC) is frequently preceded by cirrhosis and poses a significant public health challenge in the United States (US). Recent decades have seen notable shifts in the epidemiological patterns of LC, yet national data guiding the optimal allocation of resources and preventive efforts remain limited. This study aims to investigate the current trends, risk factors, and outcomes of LC in the US. Methods This study utilized the Global Burden of Disease (GBD) dataset to collect data on the annual incident cases, deaths, Disability-Adjusted Life Years (DALYs), age-standardized incidence rates (ASIR), age-standardized death rates, and age-standardized DALY rates of primary LC and its etiologies and risk factors, between 1990 and 2019. Percentage changes in incident cases, DALYs, and deaths and the estimated annual percentage change (EAPC) in ASIR and deaths rates of LC were calculated to conduct temporal analysis. Linear regression was applied for the calculation of EAPCs. Correlations of EAPC with socio-demographic index (SDI) were separately evaluated by Pearson correlation analyses. Results We observed a marked increase in the ASIR of LC, increasing from 2.22 (95% CI: 2.15-2.27) per 100,000 people in 1990 to 5.23 (95% CI: 4.28-6.29) per 100,000 people in 2019, a percentage change of 135.4%. LC due to hepatitis C followed by alcohol use were the primary factors driving this increase. The ASIR and age-standardized death rates of LC showed a significant average annual increase of 3.0% (95% CI: 2.7-3.2) and 2.6% (95% CI: 2.5-2.8), respectively. There was a significant negative correlation between the SDI and the EAPC in ASIR (rho = -0.40, p = 0.004) and age-standardized death rates (rho = -0.46, p < 0.001). In 2019, drug and alcohol use, followed by elevated body mass index (BMI) were the primary risk factors for age-standardized DALY rates attributable to LC. Conclusion The increased burden of LC in the US highlights the need for interventions. This is particularly important given that LC is mostly influenced by modifiable risk factors, such as drug and alcohol use, and elevated BMI. Our findings highlight the urgent need for public health interventions targeting socio-economic, lifestyle, and modifiable risk factors to mitigate the escalating burden of LC.
引用
收藏
页数:13
相关论文
共 58 条
[1]   Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection [J].
Ghany M.G. ;
Morgan T.R. .
HEPATOLOGY, 2020, 71 (02) :686-721
[2]   Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005 [J].
Altekruse, Sean F. ;
McGlynn, Katherine A. ;
Reichman, Marsha E. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (09) :1485-1491
[3]  
[Anonymous], SEER cancer stat facts: liver and intrahepatic bile duct cancer
[4]   Race, Ethnicity, and Socioeconomic Status Influence the Survival of Patients With Hepatocellular Carcinoma in the United States [J].
Artinyan, Avo ;
Mailey, Brian ;
Sanchez-Luege, Nicelio ;
Khalili, Joshua ;
Sun, Can-Lan ;
Bhatia, Smita ;
Wagman, Lawrence D. ;
Nissen, Nicholas ;
Colquhoun, Steven D. ;
Kim, Joseph .
CANCER, 2010, 116 (05) :1367-1377
[5]   Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis [J].
Aspinall, Esther J. ;
Nambiar, Dhanya ;
Goldberg, David J. ;
Hickman, Matthew ;
Weir, Amanda ;
Van Velzen, Eva ;
Palmateer, Norah ;
Doyle, Joseph S. ;
Hellard, Margaret E. ;
Hutchinson, Sharon J. .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2014, 43 (01) :235-248
[6]   Vested Interests in Addiction Research and Policy The influence of industry actions on the availability of alcoholic beverages in the African region [J].
Babor, Thomas F. ;
Robaina, Katherine ;
Jernigan, David .
ADDICTION, 2015, 110 (04) :561-571
[7]   Global, Regional, and National Trends in Incidence and Mortality of Primary Liver Cancer and Its Underlying Etiologies from 1990 to 2019: Results from the Global Burden of Disease Study 2019 [J].
Cao, Guiying ;
Liu, Jue ;
Liu, Min .
JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH, 2023, 13 (02) :344-360
[8]  
CDC, Testing recommendations for hepatitis C virus infection
[9]  
Centers for Disease Control and Prevention (CDC), 2024, Hepatitis C Surveillance in the United States for 2019
[10]   The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association [J].
Chalasani, Naga ;
Younossi, Zobair ;
Lavine, Joel E. ;
Diehl, Anna Mae ;
Brunt, Elizabeth M. ;
Cusi, Kenneth ;
Charlton, Michael ;
Sanyal, Arun J. .
HEPATOLOGY, 2012, 55 (06) :2005-2023